Novasep
Lyon, France
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (6)
○ EMA GMP
○ MHRA GMP
Quick Facts: Novasep
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Lyon, France
- Modalities
- Small Molecule API, HPAPI / High-Potency API, ADC (Antibody-Drug Conjugate), Lentiviral Vector, Biologics (Recombinant Proteins, mAbs), Oligonucleotide, Peptide, Chromatography / Purification Services
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Novasep
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, HPAPI / High-Potency API, ADC (Antibody-Drug Conjugate), Lentiviral Vector, Biologics (Recombinant Proteins, mAbs), Oligonucleotide, Peptide, Chromatography / Purification Services
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (8 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press6 articles
Broad modality coverage (8 modalities)
Recent News 6 articles
Axplora Aims to Make Pharmaceutical Supply Chains More Stable - CHEManager
After peptide expansion, Axplora hits the gas to boost ADC capacity at French facility - Fierce Pharma
PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale - PR Newswire
PharmaZell and Novasep Merge to Create CDMO and API Manufacturer - Contract Pharma
Axplora appoints Dr Stephan Haitz as President of Novasep CDMO Business Unit - Express Pharma
Thermo Fisher Takes Deep Dive into Cell and Gene Therapy with Viral Vector Business Buy - BioSpace
Frequently Asked Questions About Novasep
What is Novasep's CDMO Signal Score?
Novasep has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Novasep for a manufacturing program?
Use the free AI matchmaker to compare Novasep against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
EUROAPI
Paris, France
Small Molecule API, Microbial Fermentation API, Oligonucleotide, Peptide, HPAPI
Veranova
Devens, MA
Small Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide
Asymchem / AsymBio
Morrisville, NC (US HQ); Tianjin, China (primary manufacturing)
Glycan GMP synthesis, Glyco-remodeling ADC conjugation (GlycoConnect, GlycoT, DisacLink, iGDC platforms), Oligonucleotide, Small Molecule API, Peptide, ADC / Bioconjugates, Flow chemistry
WuXi STA (Shanghai SynTheAll Pharmaceutical Co., Ltd.)
Shanghai, China
Small Molecule API, Advanced Pharmaceutical Intermediates, HPAPI, ADC Payload / Linker (e.g., MMAE, Exatecan, Mafodotin), Oligonucleotide, Drug Product (via PDS merger), Formulation Development, Clinical Trial Material
Axplora
Raubling, Germany
Small Molecule API, HPAPI / High-Potency API, Steroids / Corticosteroids, ADC Payload / Linker, Oligonucleotide / Peptide (purification), Preparative Chromatography, Flow Chemistry, Hazardous Chemistry, Lyophilization